Insider Trades Roundup: Arconic, Walgreens, Alphabet

- By Tiziano Frateschi

The GuruFocus All-in-One Screener can be used to find insider trades from the past week. Under the Insiders tab, change the settings for All Insider Buying to "$2,000,000+," the duration to "February 2017" and All Insider Sales to "$5,000,000+."


According to the above filters, the following are trades from company insiders this week.

Elliott Associates LP and Elliott International LP, 10% owner of Arconic Inc. (ARNC), bought a total of 249,000 shares at prices between $25.88 and $26.36 per share on Feb. 6, 7, 8 and 9. Since then, the price of the stock has risen to $27.30.

The company has an institutional ownership of 36.57% and insider ownership of 0.29%. It develops and manufactures engineered products and solutions for the aerospace, industrial gas turbine, commercial transportation and oil and gas markets. Engineered Products and Solutions offers comprehensive capabilities, from advanced alloy and 3D printing powder development to advanced manufacturing and qualification expertise.

During the last 12 months, the price of the stock has risen by 32% and the price is 0.37% below its 52-week high and 58.93% above its 52-week low.

Legion Partners Asset Management, director and 10% owner of Ciber Inc. (CBR), bought 2,428,705 shares in the company for 31 cents per share on Feb. 7. Since then, the price of the stock has risen by 25.8% to 39 cents.

The company has an institutional ownership of 76.55% and insider ownership of 12.38%. It is an information technology services company. The company solves complex IT and business issues across various industries such as manufacturing, healthcare and life sciences, communications, energy and utilities and financial services.

During the last 12 months, the price of the stock has dropped by 86% and is now trading with a PB ratio of 0.22. The price is 85.96% below its 52-week high and 81.82% above its 52-week low.

Barra Ornella, Co-COO of Walgreens Boots Alliance Inc. (WBA), bought 124,000 shares of the company for $80.93 per share on Feb. 7. Since then, the price of the stock has risen by 1.8% to $82.38.

The company has an institutional ownership of 61.92% and insider ownership of 0.82%. It operates drugstores in the U.S. It provides consumer goods and services, pharmacy and health and wellness services.

During the last 12 months, the price of the stock has risen by 9% and is now trading with a P/B ratio of 3.01. The price is 7.35% below its 52-week high and 13.02% above its 52-week low.